Neurodegenerative basis of age-related cognitive decline

Neurology

Volumn 75, Issue 12, 2010, Pages 1070-1078

  Wilson, R S ^a,b   Leurgans, S E ^a   Boyle, P A ^b   Schneider, J A ^a,c,d   Bennett, D A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Departments of Behavioral Sciences   (United States)

^c The Departments of Pathology   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; AUTOPSY; BRAIN INFARCTION; CLERGY; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; EPISODIC MEMORY; FEMALE; FOLLOW UP; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; RELIGION; SEMANTIC MEMORY; WORKING MEMORY; AGE; BRAIN; LONGITUDINAL STUDY; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY;

AGE FACTORS; AGING; BRAIN; COGNITION; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; LEWY BODIES; LONGITUDINAL STUDIES; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS;

EID: 77957241491     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f39adc     Document Type: Article

References (30)

1. Green MS, Kaye JA, Ball MJ. The Oregon Brain Aging Study: neuropathology accompanying healthy aging in the oldest old. Neurology 2000;54:105-113.
2. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer's disease and dementia: a clinico-pathologic study. Arch Neurol 2005;62:758-765.
3. Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neu-rofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729-736.
4. Petersen RC, Parisi JE, Dickson DW, et al. Neuropatho-logic features of amnestic mild cognitive impairment. Arch Neurol 2006;63:665-672.
5. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006;62:38-46.
6. Driscoll I, Resnick SM, Troncoso JC, An Y, O'Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol 2006;60:688-695.
7. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions. Neurology 2005;64:834-841.
8. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropa-thology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66: 1837-1844.
9. Wilson RS, Bienias JL, Evans DA, Bennett DA. Religious Orders Study: overview and change in cognitive and motor speed. Aging Neuropsychol Cogn 2004;11:280-303.
10. Wilson RS, Beckett LA, Bienias JL, Evans DA, Bennett DA. Terminal decline in cognitive function. Neurology 2003;60:1782-1787.
11. Wilson RS, Beck TL, Bienias JL, Bennett DA. Terminal cognitive decline: accelerated loss of cognition in the last years of life. Psychosom Med 2007;69:131-137.
12. Thorvaldsson V, Hofer SM, Berg S, Skoog I, Sacuiu S, Johansson B. Onset of terminal decline in cognitive abilities in individuals without dementia. Neurology 2008;71: 882-887.
13. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
14. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009;66:200-208.
15. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69: 2197-2204.
16. Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003;60:1082-1088.
17. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004;62: 1148-1155.
18. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004;61:378-384.
19. Sliwinski MJ, Strawski RS, Hall CB, Katz M, Verghese J, Lipton R. Distinguishing preterminal and terminal cognitive decline. Eur Psychol 2006;11:172-181.
20. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
21. Howieson DB, Carlson NE, Moore MM, et al. Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc 2008;14:192-198.
22. Amieva H, Jacqmin-Gadda H, Orgogozo JM, et al. The 9 year cognitive decline before dementia of Alzheimer type: a prospective population-based study. Brain 2005;128:1093-1101.
23. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008;14:266-278.
24. Baltes P, Nesserlroade J. History and rationale of longitudinal research. In: Nesserlroade J, Baltes P, eds. Longitudinal Research in the study of Behavior or Development. Sand Diego, CA: Academic Press; 1979:1-39.
25. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
26. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-231.
27. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 im-munoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61:435-444.
28. Josephs KA, Whitewell JL, Knopman DS, et al. Abnormal TDP-43 immunoreactivity in AD modifies clinico-pathologic and radiologic phenotype. Neurology 2008;70: 1850-1857.
29. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-580.
30. Scheff SW, Price DA, Schmitt FA, Dekosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007;68: 1505-1508.